Champions Oncology, Inc.
NASDAQ:CSBRBiotechnology
-$0.08 today
- Market cap
- $63.91M
- Beta
- 0.40
- P/E (TTM)
- -41.0
- EPS (TTM)
- -$0.16
Volume 0.00M
Average 0.01M
Returns on capital
Champions Oncology, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
124.6%
avg -5009.6%
ROIC
48.6%
avg -339.1%
ROA
14.5%
avg -39.0%
Analysis
ROE is currently the strongest return metric at 124.6% versus its period average of -5009.6%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Ronnie Morris | Executive Chair | USD 810.7K | 60 | 858.88K | 6.18% |
Robert Brainin | Chief Executive Officer & Director | USD 516.42K | 55 | — | — |
David Barry Miller | Chief Financial Officer | USD 340K | 57 | 0 | <0.01% |
Maria Mancini | Chief Operating Officer | — | — | — | — |
Marianna Zipeto | Executive Vice President of Growth, Strategy & Enablement | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 17, 2023.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +104.3% | N/A0 analysts |
| Revenue | N/A | N/A | +5.1% | +7.5% (3yr)1 analysts |
| Net Income | N/A | N/A | +104.7% | N/A1 analysts |
| EBIT | N/A | N/A | +99.9% | N/A — |
Analysis
Recent growth has been strongest in Net Income at +104.7% over three years. Forward estimates point to Revenue at +7.5% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Champions Oncology, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CSBR's management, answered from reported figures.
Who manages CSBR?
Champions Oncology, Inc. (CSBR) lists 5 active executives. The top listed executive is Maria Mancini, Chief Operating Officer.
Are CSBR insiders buying or selling?
Recent insider activity shows net buying of $6.30M.
Continue the stock analysis
Jump to another research area for this company.